Followed 110 TimesTop FollowedNYSE:ABBV AbbVie (ABBV) News Today $153.72 +0.11 (+0.07%) (As of 03:10 PM ET) Add Compare Share Share Today's Range$152.66▼$154.8550-Day Range$133.56▼$153.9352-Week Range$130.96▼$168.11Volume1.94 million shsAverage Volume5.62 million shsMarket Capitalization$271.32 billionP/E Ratio31.63Dividend Yield3.85%Price Target$165.79 HeadlinesProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline3 Bargain Stocks to Buy in a Market That's Priced for Perfectionfinance.yahoo.com - September 21 at 2:56 PMUS pharma group AbbVie opens new €23m Dublin facilitymsn.com - September 21 at 9:55 AMAbbVie (NYSE:ABBV) Has A Pretty Healthy Balance Sheetfinance.yahoo.com - September 21 at 9:55 AMAbbVie Inc. (NYSE:ABBV) Shares Sold by Redhawk Wealth Advisors Inc.marketbeat.com - September 21 at 7:36 AMThis Proven 200% Dividend Growth Strategy Is a Peter Lynch Favoritemarketbeat.com - September 20 at 10:03 PMLeading Players Pfizer, AbbVie, and Novartis at the Forefront of Advancements in Plaque Psoriasis Treatmentbenzinga.com - September 20 at 6:29 PMAbbVie Inc. stock outperforms market on strong trading daymarketwatch.com - September 20 at 6:29 PMSymphony Financial Ltd. Co. Has $967,000 Holdings in AbbVie Inc. (NYSE:ABBV)marketbeat.com - September 20 at 7:24 AMFlee to Healthcare Stocks if Recession Rears its Head? (ABBV)marketbeat.com - September 20 at 7:04 AMFormer IBD 50 Stock Revance Implodes As Its 'Prestige' Plan Goes Up In Smokefinance.yahoo.com - September 19 at 2:56 PMAbbVie Inc. (NYSE:ABBV) Shares Sold by MJP Associates Inc. ADVmarketbeat.com - September 19 at 7:40 AM3 Healthcare Stocks to Buy Todaystocknews.com - September 18 at 9:06 PMAbbVie's Botox Meets Key Goals in 2nd Platysma Prominence Studymarketwatch.com - September 18 at 1:39 PMAbbVie: Company Vs. Stock, A Gentle Facelift Would Be Nice (Technical Analysis)msn.com - September 18 at 1:39 PMAbbvie (ABBV) Declares $1.48 Dividendmsn.com - September 17 at 2:01 PMFoster Group Inc. Sells 715 Shares of AbbVie Inc. (NYSE:ABBV)marketbeat.com - September 17 at 7:48 AMAbbVie (ABBV) Fell in Q2 Due to Competitionfinance.yahoo.com - September 15 at 10:04 AMArmstrong Advisory Group Inc. Cuts Stock Position in AbbVie Inc. (NYSE:ABBV)marketbeat.com - September 15 at 8:44 AMAbbVie Inc.barrons.com - September 14 at 10:52 PMAbbVie Currently Up Six Consecutive Days, On Track for Longest Winning Streak Since March 2022 — Data Talkmorningstar.com - September 14 at 5:51 PMDuality Advisers LP Invests $5.30 Million in AbbVie Inc. (NYSE:ABBV)marketbeat.com - September 14 at 8:57 AMZacks Investment Ideas feature highlights: Novo Nordisk, Eli Lilly and AbbViefinance.yahoo.com - September 14 at 7:50 AM3 A-Rated Pharma Stocks to Buy Todaystocknews.com - September 13 at 6:19 PMAbbVie Unusual Options Activity For September 13benzinga.com - September 13 at 4:49 PMHarpoon Shares Drop 7.3% as AbbVie Declines License Optionmarketwatch.com - September 13 at 4:49 PMAbbVie's (ABBV) Skyrizi Crohn's Disease Study Meets Goalsfinance.yahoo.com - September 13 at 4:49 PMAbbVie Calls on Public to Vote for the 2023 AbbVie Cystic Fibrosis Scholarship "Thriving Students"finance.yahoo.com - September 13 at 4:49 PMAbbVie Inc. (ABBV) Management Presents at Morgan Stanley 21st Annual Global Healthcare Brokers Conference 2023 (Transcript)seekingalpha.com - September 13 at 4:01 PMEmpower Advisory Group LLC Buys Shares of 484,104 AbbVie Inc. (NYSE:ABBV)marketbeat.com - September 13 at 11:39 AMAbbVie (ABBV) Gets a Hold from Goldman Sachsmarkets.businessinsider.com - September 12 at 11:15 PMAbbVie Reports Top-line Results From Phase 3 SEQUENCE Clinical Trial Of Risankizumabmarkets.businessinsider.com - September 12 at 6:14 PMIs AbbVie (ABBV) a Buy as Wall Street Analysts Look Optimistic?finance.yahoo.com - September 12 at 6:14 PMStrategic Global Advisors LLC Sells 5,720 Shares of AbbVie Inc. (NYSE:ABBV)marketbeat.com - September 12 at 1:43 PMHigh Yield, Low Beta Stocks to Buy for the Next Market Meltdown (ABBV)marketbeat.com - September 12 at 7:10 AMShould You Hold AbbVie (ABBV)?finance.yahoo.com - September 11 at 5:14 PM(ABBV) - Analyzing AbbVie's Short Interestbenzinga.com - September 10 at 10:39 PMPossible Bearish Signals With AbbVie Insiders Disposing Stockfinance.yahoo.com - September 10 at 4:42 PMAbbVie Inc. (NYSE:ABBV) Shares Sold by Ensign Peak Advisors Incmarketbeat.com - September 10 at 1:50 PMVeritable L.P. Cuts Position in AbbVie Inc. (NYSE:ABBV)marketbeat.com - September 8 at 3:43 PMAlector (ALEC) Up 7% on Finishing Enrolment in Alzheimer Studyfinance.yahoo.com - September 8 at 2:51 PMAbbVie Inc. Plans Quarterly Dividend of $1.48 (NYSE:ABBV)marketbeat.com - September 8 at 12:53 PMStifel Financial Corp Sells 248,671 Shares of AbbVie Inc. (NYSE:ABBV)marketbeat.com - September 7 at 4:18 PMAlector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Diseasefinance.yahoo.com - September 7 at 7:10 AMJoin BOTOX® Cosmetic (onabotulinumtoxinA) and IFundWomen in Supporting Women Entrepreneursfinance.yahoo.com - September 6 at 9:59 AMUK MHRA approves AbbVie’s migraine prevention drug Aquiptamsn.com - September 5 at 1:58 PMHere’s Why AbbVie (ABBV) Declined in Q2insidermonkey.com - September 5 at 1:58 PMAbbVie Unleashed: 4% Yield, Potentially 40% Undervaluedmsn.com - September 4 at 6:27 PMTop 3 Pharma Stocks to Boost Your Portfoliostocknews.com - September 4 at 3:11 PMAbbVie: Proving The Bears Wrong Again As Shares Surgedseekingalpha.com - September 4 at 2:09 PMAbbVie: Balance Is Everythingmsn.com - September 4 at 2:15 AM Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address ABBV Media Mentions By Week ABBV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼0.780.46▲Average Medical News Sentiment ABBV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼2016▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PFE News Today JNJ News Today MRK News Today NVS News Today AZN News Today TMO News Today ABT News Today AMGN News Today SNY News Today BMY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NYSE:ABBV) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.